ECA (Ephedrine, Caffeine, and Aspirin) Stack Information

1) Conditions Studied

• Weight Loss and Obesity Management
• Enhanced Athletic Performance
• Temporary Relief of Mild to Moderate Pain
• Some studies have explored its use in treating narcolepsy and depression

2) Efficacy in Treating Conditions

The ECA stack has shown some effectiveness in promoting short-term weight loss and improving athletic performance, but its long-term benefits and safety are controversial. Evidence for its use in treating other conditions such as narcolepsy and depression is limited and inconclusive.

3) Health Benefits

• Short-term weight loss
• Increased energy levels
• Potential enhancement of athletic performance
• Temporary alleviation of pain due to aspirin's analgesic properties

4) Downsides

• Increased risk of cardiovascular issues such as hypertension and arrhythmias
• Potential for negative side effects including anxiety, insomnia, and gastrointestinal distress
• May lead to dependency or abuse due to its stimulating properties
• Aspirin can cause gastrointestinal bleeding or ulcers in some individuals

5) Impact on Specific Genetic Variations

Currently, there is limited research on how ECA might affect individuals with specific genetic variations. However, genetic factors can influence individual responses to stimulants like ephedrine and caffeine, as well as the risk of side effects. Individuals with certain genetic profiles may metabolize these compounds differently, leading to either diminished effects or increased susceptibility to adverse reactions. Consulting with a healthcare provider for genetic testing and personalized advice is recommended before using ECA.

Ephedrine and Caffeine for Weight Loss: Research Findings

The research on the effects of ephedrine (E) and caffeine (C) combination, known as ECA, has shown significant benefits for weight loss in obese patients on a restricted calorie diet. A study with 180 participants revealed that the ECA combination led to a greater weight loss compared to ephedrine alone, caffeine alone, or placebo over 24 weeks. Minor side effects were reported but subsided after eight weeks.

Study Results

• The ECA group showed significantly greater weight loss from week 8 to week 24 compared to the placebo group.
• Side effects such as tremor, insomnia, and dizziness were temporary.
• After a two-week break, an additional 24-week treatment resulted in a significant weight loss of 1.1kg.
• An 8-week study confirmed ECA's role in conserving lean body mass.

Thermogenic Effects

A study measuring the thermogenic response in volunteers found that the E 20 mg/C 200 mg combination produced the greatest effect. All E + C combinations increased systolic blood pressure more than expected from additive effects.

Pharmacological Interactions

A crossover study involving 16 healthy adults showed that the ECA combination significantly increased cardiovascular, metabolic, and hormonal responses. These effects are likely due to pharmacodynamic interactions.

Conclusions

In summary, the ECA combination has been proven effective for weight loss and preserving lean body mass in obese patients, with only minor and temporary side effects. The combination also has significant thermogenic and pharmacological effects, indicating a synergistic interaction between ephedrine and caffeine.

References:

1. The effect and safety of an ephedrine/caffeine compound compared to ephedrine, caffeine and placebo in obese subjects on an energy restricted diet. A double blind trial
2. Safety and efficacy of long-term treatment with ephedrine, caffeine and an ephedrine/caffeine mixture
3. Thermogenic synergism between ephedrine and caffeine in healthy volunteers: a double-blind, placebo-controlled study
4. Enhanced stimulant and metabolic effects of combined ephedrine and caffeine

Upload Whole Genome Sequencing (WGS) raw DNA data today and take a deep dive into your genome!

Or if you only have standard microarray data currently, upload raw DNA data to get started with your free DNA raw data analysis today!